Real-time shear wave versus transient elastography for predicting fibrosis: Applicability, and impact of inflammation and steatosis. a non-invasive comparison

PLoS ONE

Volumn 11, Issue 10, 2016, Pages

  Poynard, Thierry ^a,b,d   Pham, Tam ^a   Perazzo, Hugo ^a   Munteanu, Mona ^c,g   Luckina, Elena ^a   Elaribi, Djamel ^a   Ngo, Yen ^c,g   Bonyhay, Luminita ^a,d   Seurat, Noemie ^a,d   Legroux, Muriel ^a,d   Ngo, An ^c,g   Deckmyn, Olivier ^c,g   Thabut, Dominique ^a,d   Ratziu, Vlad ^a,d   Lucidarme, Olivier ^a,e   Lebray, Pascal ^d   Moussalli, Joseph ^d   Fartoux, Laetitia ^d   Rosmorduc, Olivier ^d   Imbert Bismut, Françoise ^f   Drane, Fabienne ^g   Castille, Jean Marie ^g   more..

^a SORBONNE UNIVERSITÉ   (France)

^b CENTRE DE RECHERCHE SAINT ANTOINE   (France)

^c Hepatology UPMC APHP Liver Center   (France)

^d Hepatology Unit   (France)

^e Radiology Department   (France)

^f PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^g BioPredictive Paris   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BODY MASS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC EQUIPMENT; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; ECHOGRAPH; ECHOGRAPHY; ELASTICITY; ELASTOGRAPHY; FATTY LIVER; GOLD STANDARD; HEPATITIS; HUMAN; INTERMETHOD COMPARISON; LIVER FIBROSIS; MAJOR CLINICAL STUDY; NON INVASIVE MEASUREMENT; PRACTICE GUIDELINE; PREDICTION; QUANTITATIVE DIAGNOSIS; REAL TIME SHEAR WAVE ELASTOGRAPHY; RECEIVER OPERATING CHARACTERISTIC; REFERENCE VALUE; RELIABILITY; STANDARDIZATION; TRANSIENT ELASTOGRAPHY; VALIDATION STUDY; AREA UNDER THE CURVE; BLOOD; CLINICAL TRIAL; COMPARATIVE STUDY; DIAGNOSTIC IMAGING; FEMALE; INFLAMMATION; LIVER CIRRHOSIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOLOGY; PROCEDURES; SEVERITY OF ILLNESS INDEX;

BIOLOGICAL MARKER;

AREA UNDER CURVE; BIOMARKERS; ELASTICITY IMAGING TECHNIQUES; FATTY LIVER; FEMALE; HUMANS; INFLAMMATION; LIVER CIRRHOSIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ROC CURVE; SEVERITY OF ILLNESS INDEX;

EID: 84991383985     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0163276     Document Type: Article

References (30)

1. Muller M, Gennisson JL, Deffieux T, Tanter M, Fink M (2009) Quantitative viscoelasticity mapping of human liver using supersonic shear imaging: preliminary in vivo feasibility study. Ultrasound Med Biol 35:219-229. doi: 10.1016/j.ultrasmedbio.2008.08.018 PMID: 19081665
2. EASL-ALEH Clinical Practice Guidelines (2015) Non-invasive tests for evaluation of liver disease severity and prognosis. J Hepatol; 63:237-264. doi: 10.1016/j.jhep.2015.04.006 PMID: 25911335
3. Ferraioli G, Tinelli C, Bello BD, Zicchetti M, Filice G, Filice C (2012) Accuracy of real-time shear wave elastography for assessing liver fibrosis in chronic hepatitis C: A pilot study. Hepatology 56:2125-2133. doi: 10.1002/hep.25936 PMID: 22767302
4. Poynard T, Munteanu M, Luckina E, Perazzo H, Ngo Y, Royer Luca, et al (2013) Liver fibrosis evaluation using real-time shear wave elastography: applicability and diagnostic performance using methods without a gold standard. J Hepatol 58:928-935. doi: 10.1016/j.jhep.2012.12.021 PMID: 23321316
5. Pellot-Barakat C, Lefort M, Chami L, Labit M, Frouin F, Lucidarme Olivier (2015) Automatic assessment of shear wave elastography quality and measurement reliability in the liver. Ultrasound Med Biol 41:936-943. doi: 10.1016/j.ultrasmedbio.2014.11.010 PMID: 25701517
6. Poynard T, de Ledinghen V, Zarski JP, Stanciu C, Munteanu M, Vergniol Julien, et al. (2012) Relative performances of FibroTest, Fibroscan and biopsy for assessing the stage of liver fibrosis in patients with chronic hepatitis C: a step toward the truth in the absence of a gold standard. J Hepatol 56:541-548. doi: 10.1016/j.jhep.2011.08.007 PMID: 21889468
7. Sporea I, GrǍdinaru-TaşcǍu O, Bota S, Popescu A, Sirli R, Jurchis A, et al. (2013) How many measurements are needed for liver stiffness assessment by 2D-Shear Wave Elastography (2D-SWE) and which value should be used: the mean or median? Med Ultrason 15:268-72. doi: 10.11152/mu.2013. 2066.154.isp2 PMID: 24286089
8. Elkrief L, Rautou PE, Ronot M, Lambert S, Dioguardi M, Francoz C, et al. (2015) Prospective comparison of spleen and liver stiffness by using shear-wave and transient elastography for detection of portal hypertension in cirrhosis. Radiology 275:589-98. doi: 10.1148/radiol.14141210 PMID: 25469784
9. Friedrich-Rust M, Poynard T, Castera L (2016) Critical comparison of elastography methods to assess chronic liver disease. Nat Rev Gastroenterol Hepatol 13:402-11. doi: 10.1038/nrgastro.2016.86 PMID: 27273167
10. de Lédinghen V, Wong GL, Vergniol J, Chan HL, Hiriart JB, Chan AW, et al (2016) Controlled Attenuation parameter (CAP) for the diagnosis of steatosis in NonAlcoholic Fatty Liver Disease. J Gastroenterol Hepatol 31:848-55. doi: 10.1111/jgh.13219 PMID: 26514665
11. Poynard T, Munteanu M, Deckmyn O, Ngo Y, Drane F, Messous D, et al. (2011) Applicability and precautions of use of liver injury biomarker FibroTest. A reappraisal at 7 years of age BMC Gastroenterol 11:e39. doi: 10.1186/1471-230X-11-39 PMID: 21492460
12. Poynard T, Munteanu M, Ngo Y, Castera L, Halfon P, Ratziu V, et al. (2010) ActiTest accuracy for the assessment of histological activity grades in patients with chronic hepatitis C, an overview using Obuchowski measure. Gastroenterol Clin Biol 34:388-96. doi: 10.1016/j.gcb.2010.05.001 PMID: 20580175
13. Poynard T, Ratziu V, Naveau S, Thabut D, Charlotte F, Messous D, et al. (2005) The diagnostic value of biomarkers (SteatoTest) for the prediction of liver steatosis Comp Hepatol 4:10. doi: 10.1186/1476- 5926-4-10 PMID: 16375767
14. de Lédinghen V, Wong VW, Vergniol J, Wong GL, Foucher J, Chu SH, et al. (2012) Diagnosis of liver fibrosis and cirrhosis using liver stiffness measurement: comparison between M and XL probe of FibroScan®. J Hepatol 56:833-839. doi: 10.1016/j.jhep.2011.10.017 PMID: 22173167
15. Watson PF, Petrie A (2010) Method agreement analysis: a review of correct methodology Theriogenology 73:1167-1179. doi: 10.1016/j.theriogenology.2010.01.003 PMID: 20138353
16. Zhou X, Obuchowski N, McClish D (2002) Statistical Methods in Diagnostic Medicine. John Wiley & Sons.
17. Schuetz GM, Schlattmann P, Dewey M (2012) Use of 3x2 tables with an intention to diagnose approach to assess clinical performance of diagnostic tests: meta-analytical evaluation of coronary CT angiography studies BMJ 345:e6717. doi: 10.1136/bmj.e6717 PMID: 23097549
18. Houot M, Ngo Y, Munteanu M, Marque S, Poynard T (2016) Systematic review with meta-analysis: direct comparisons of biomarkers for the diagnosis of fibrosis in chronic hepatitis C and B. Aliment Pharmacol Ther 43:16-29. doi: 10.1111/apt.13446 PMID: 26516104
19. Hintze J (2003) NCSS 2013, LCC. Kaysville, Utah, USA. www.ncss.com.
20. Bedossa P, Dargère D, Paradis V (2003) Sampling variability of liver fibrosis in chronic hepatitis C Hepatology 38:1449-57. doi: 10.1016/j.hep.2003.09.022 PMID: 14647056
21. Ratziu V, Charlotte F, Heurtier A, Gombert S, Giral P, Bruckert E, et al. (2005) Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology 128:1898-906. doi: 10.1053/j.gastro. 2005.03.084 PMID: 15940625
22. Poynard T, Deckmyn O, Munteanu M, Ngo Y, Drane F, Castille JM, et al. (2015) Awareness of the severity of liver diseases re-examined using software-combined biomarkers of liver fibrosis and necroinflammatory activity BMJ Open 5:e010017. doi: 10.1136/bmjopen-2015-010017 PMID: 26700292
23. Poynard T, Vergniol J, Ngo Y, Foucher J, Munteanu M, Merrouche W, et al. (2014) Staging chronic hepatitis C in seven categories using fibrosis biomarker (FibroTest™) and transient elastography (FibroScan®) J Hepatol 60:706-14. doi: 10.1016/j.jhep.2013.11.016 PMID: 24291240
24. Poynard T, Vergniol J, Ngo Y, Foucher J, Thibault V, Munteanu M, et al. (2014) Staging chronic hepatitis B into seven categories, defining inactive carriers and assessing treatment impact using a fibrosis biomarker (FibroTest®) and elastography (FibroScan®) J Hepatol 61:994-1003. doi: 10.1016/j.jhep. 2014.06.027 PMID: 25016224
25. Poynard T, Munteanu M, Colombo M, Bruix J, Schiff E, Terg R, et al. (2011) FibroTest is an independent predictor of virologic response in chronic hepatitis C patients retreated with pegylated interferon alfa-2b and ribavirin in the EPIC program. J Hepatol 54:227-35. doi: 10.1016/j.jhep.2010.06.038 PMID: 21056496
26. Munteanu M, Tiniakos D, Anstee Q, Charlotte F, Marchesini G, Bugianesi E, et al. (2016) Diagnostic performance of FibroTest, SteatoTest, and ActiTest in patients with NAFLD using the SAF-score as histological reference. Alim Pharmacol Ther 44:877-89. doi: 10.1111/apt.13770 PMID: 27549244
27. Poynard T, Munteanu M, Deckmyn O, Ngo Y, Drane F, Castille JM, et al. (2012) Validation of liver fibrosis biomarker (FibroTest) for assessing liver fibrosis progression: proof of concept and first application in a large population. J Hepatol; 57:541-8. doi: 10.1016/j.jhep.2012.04.025 PMID: 22612998
28. Castéra L, Foucher J, Bernard PH, Carvalho F, Allaix D, Merrouch W, et al. (2010) Pitfalls of liver stiffness measurement: a 5-year prospective study of 13, 369 examinations. Hepatology 51:828-835. doi: 10.1002/hep.23425 PMID: 20063276
29. Macaluso FS, Maida M, Camma C, Cabibbo G, Cabibi D, Alduino R, et al. (2014) Steatosis affects the performance of liver stiffness measurement for fibrosis assessment in patients with genotype 1 chronic hepatitis C J Hepatol 61:523-529. doi: 10.1016/j.jhep.2014.04.045 PMID: 24815874
30. Chung JH, Ahn HS, Kim SG, Lee YN, Kim YS, Jeong SW, et al (2013). The usefulness of transient elastography, acoustic-radiation-force impulse elastography, and real-time elastography for the evaluation of liver fibrosis. Clin Mol Hepatol; 19:156-64. doi: 10.3350/cmh.2013.19.2.156 PMID: 23837140